Collegeville, PA, United States of America

Kenneth Wiggall

USPTO Granted Patents = 12 

 

 

Average Co-Inventor Count = 4.6

ph-index = 4

Forward Citations = 40(Granted Patents)


Company Filing History:


Years Active: 2008-2025

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):

Title: Kenneth Wiggall: Innovator in Pharmaceutical Chemistry

Introduction

Kenneth Wiggall is a notable inventor based in Collegeville, PA (US), recognized for his contributions to pharmaceutical chemistry. He holds a total of 12 patents, showcasing his innovative spirit and dedication to advancing medical science.

Latest Patents

Among his latest patents is the invention of Triazole-substituted imidazo[1,2-a]pyrimidines as cGAS inhibitors. This invention relates to compounds that are useful in treating various disorders, particularly autoimmune and immune-mediated conditions such as systemic lupus erythematosus (SLE), cutaneous lupus erythematosus (CLE), and lupus nephritis. Another significant patent involves Prolyl hydroxylase inhibitors, which are certain pyrimidinetrione N-substituted glycine derivatives that act as antagonists of HIF prolyl hydroxylases. These compounds are beneficial for treating diseases that can be improved by inhibiting this enzyme, with anemia being a prime example.

Career Highlights

Kenneth has worked with prominent companies in the pharmaceutical industry, including GlaxoSmithKline LLC and SmithKline Beecham Corporation. His work in these organizations has significantly contributed to the development of innovative treatments and therapies.

Collaborations

Throughout his career, Kenneth has collaborated with esteemed colleagues such as Antony N Shaw and Duke M Fitch. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Kenneth Wiggall's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the field. His work continues to impact the treatment of various medical conditions, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…